Resumen
Although magnesium sulfate is widely used as a tocolytic agent in the hope of preventing spontaneous preterm birth, there is a paucity of data from large well-designed randomized clinical studies demonstrating the efficacy of magnesium sulfate therapy. Given the potential for untoward side effects and the inherent risks of magnesium sulfate therapy, a thorough understanding of the potential risks and benefits of this agent is needed. To accomplish this understanding we have provided a detailed review the history, pharmacology, physiology, maternal/fetal side effects, and tocolytic efficacy of magnesium sulfate.
| Idioma original | English (US) |
|---|---|
| Páginas (desde-hasta) | 236-247 |
| Número de páginas | 12 |
| Publicación | Seminars in Perinatology |
| Volumen | 25 |
| N.º | 4 |
| DOI | |
| Estado | Published - 2001 |
| Publicado de forma externa | Sí |
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Pediatrics, Perinatology, and Child Health